Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients. - Yang,W.S.; Jeng,C.Y.; Wu,T.J.; Tanaka,S.; Funahashi,T.; Matsuzawa,Y.; Wang,J.P.; Chen,C.L.; Tai,T.Y.; Chuang,L. (Diabetes Care, 2002)